Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROFECOXIB vs ROMOSOZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROFECOXIB vs ROMOSOZUMAB: Safety Overview

Metric ROFECOXIB ROMOSOZUMAB
Total FAERS Reports 1,238 434
Deaths Reported 56 48
Death Rate 4.5% 11.1%
Hospitalizations 176 81
Average Patient Age 63.1 yrs 69.1 yrs
% Female Patients 77.9% 94.5%
FDA Approval Date Feb 25, 2000 N/A
Manufacturer N/A Amgen, Inc
Route N/A SUBCUTANEOUS
Marketing Status Discontinued N/A